Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update


Summary

GlobalData's Medical Devices sector report, “Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Transmucosal Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Transmucosal Drug Delivery device is intended for the localized delivery of medications through a mucous membrane.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Transmucosal Drug Delivery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transmucosal Drug Delivery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transmucosal Drug Delivery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Transmucosal Drug Delivery Overview
4 Products under Development
4.1 Transmucosal Drug Delivery - Pipeline Products by Stage of Development
4.2 Transmucosal Drug Delivery - Pipeline Products by Segment
4.3 Transmucosal Drug Delivery - Pipeline Products by Territory
4.4 Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
4.5 Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
4.6 Transmucosal Drug Delivery - Ongoing Clinical Trials
5 Transmucosal Drug Delivery - Pipeline Products under Development by Companies
5.1 Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development
5.2 Transmucosal Drug Delivery – Companies Pipeline Products by Stage of Development
6 Transmucosal Drug Delivery Companies and Product Overview
6.1 AcelRx Pharmaceuticals Inc Company Overview
6.1.1 AcelRx Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
6.2 AFYX Therapeutics A/S Company Overview
6.2.1 AFYX Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview
6.3 Albert Einstein College of Medicine Company Overview
6.3.1 Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
6.4 Allergan Ltd Company Overview
6.4.1 Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.5 Altamira Medica AG Company Overview
6.5.1 Altamira Medica AG Pipeline Products & Ongoing Clinical Trials Overview
6.6 Anelleo Inc Company Overview
6.6.1 Anelleo Inc Pipeline Products & Ongoing Clinical Trials Overview
6.7 Aquestive Therapeutics Inc Company Overview
6.7.1 Aquestive Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.8 Arovella Therapeutics Ltd Company Overview
6.8.1 Arovella Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.9 ARS Pharmaceuticals, Inc. Company Overview
6.9.1 ARS Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.10 Atossa Therapeutics Inc Company Overview
6.10.1 Atossa Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.11 Auris Medical AG Company Overview
6.11.1 Auris Medical AG Pipeline Products & Ongoing Clinical Trials Overview
6.12 Auritec Pharmaceuticals Inc Company Overview
6.12.1 Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
6.13 BeFree! Company Overview
6.13.1 BeFree! Pipeline Products & Ongoing Clinical Trials Overview
6.14 Bespak Europe Ltd Company Overview
6.14.1 Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.15 Biorings LLC Company Overview
6.15.1 Biorings LLC Pipeline Products & Ongoing Clinical Trials Overview
6.16 BioXcel Therapeutics Inc Company Overview
6.16.1 BioXcel Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.17 Birmingham Biotech Ltd Company Overview
6.17.1 Birmingham Biotech Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.18 Bryn Pharma LLC Company Overview
6.18.1 Bryn Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview
6.19 Callitas Therapeutics Inc Company Overview
6.19.1 Callitas Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.20 Chulalongkorn University Company Overview
6.20.1 Chulalongkorn University Pipeline Products & Ongoing Clinical Trials Overview
6.21 Combinent BioMedical Systems Inc Company Overview
6.21.1 Combinent BioMedical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
6.22 Conrad Company Overview
6.22.1 Conrad Pipeline Products & Ongoing Clinical Trials Overview
6.23 Covidrops LLP Company Overview
6.23.1 Covidrops LLP Pipeline Products & Ongoing Clinical Trials Overview
6.24 Dare Bioscience Inc Company Overview
6.24.1 Dare Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
6.25 Eledon Pharmaceuticals Inc Company Overview
6.25.1 Eledon Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
6.26 Emergent BioSolutions Inc Company Overview
6.26.1 Emergent BioSolutions Inc Pipeline Products & Ongoing Clinical Trials Overview
6.27 EmphyCorp Inc Company Overview
6.27.1 EmphyCorp Inc Pipeline Products & Ongoing Clinical Trials Overview
6.28 Ena Respiratory Pty Ltd Company Overview
6.28.1 Ena Respiratory Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.29 Eureka Therapeutics Inc Company Overview
6.29.1 Eureka Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.30 Eveon SAS Company Overview
6.30.1 Eveon SAS Pipeline Products & Ongoing Clinical Trials Overview
6.31 Evestra Inc Company Overview
6.31.1 Evestra Inc Pipeline Products & Ongoing Clinical Trials Overview
6.32 Evofem Biosciences Inc Company Overview
6.32.1 Evofem Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
6.33 Ferring Pharmaceuticals AS Company Overview
6.33.1 Ferring Pharmaceuticals AS Pipeline Products & Ongoing Clinical Trials Overview
6.34 Firebrick Pharma Pty Ltd Company Overview
6.34.1 Firebrick Pharma Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.35 GeneOne Life Science Inc Company Overview
6.35.1 GeneOne Life Science Inc Pipeline Products & Ongoing Clinical Trials Overview
6.36 Ghent University Company Overview
6.36.1 Ghent University Pipeline Products & Ongoing Clinical Trials Overview
6.37 Glenmark Pharmaceuticals Ltd Company Overview
6.37.1 Glenmark Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.38 Grasses of Eden Ltd Company Overview
6.38.1 Grasses of Eden Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.39 Grunenthal Ltd Company Overview
6.39.1 Grunenthal Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.40 Halberd Corp Company Overview
6.40.1 Halberd Corp Pipeline Products & Ongoing Clinical Trials Overview
6.41 Harm Reduction Therapeutics Inc Company Overview
6.41.1 Harm Reduction Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.42 Hebrew University of Jerusalem Company Overview
6.42.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview
6.43 Hikma Pharmaceuticals Plc Company Overview
6.43.1 Hikma Pharmaceuticals Plc Pipeline Products & Ongoing Clinical Trials Overview
6.44 Imbed Biosciences Inc Company Overview
6.44.1 Imbed Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
6.45 Institute for Research and Innovation in Health Company Overview
6.45.1 Institute for Research and Innovation in Health Pipeline Products & Ongoing Clinical Trials Overview
6.46 Insys Therapeutics Inc (Inactive) Company Overview
6.46.1 Insys Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.47 IntelGenx Corp Company Overview
6.47.1 IntelGenx Corp Pipeline Products & Ongoing Clinical Trials Overview
6.48 International Partnership For Microbicides Company Overview
6.48.1 International Partnership For Microbicides Pipeline Products & Ongoing Clinical Trials Overview
6.49 ITC Life Sciences and Technology Centre Company Overview
6.49.1 ITC Life Sciences and Technology Centre Pipeline Products & Ongoing Clinical Trials Overview
6.50 ITF Pharma Inc Company Overview
6.50.1 ITF Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
6.51 Janssen Sciences Ireland UC Company Overview
6.51.1 Janssen Sciences Ireland UC Pipeline Products & Ongoing Clinical Trials Overview
6.52 Kane Biotech Inc Company Overview
6.52.1 Kane Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
6.53 Karessa Pharma AB Company Overview
6.53.1 Karessa Pharma AB Pipeline Products & Ongoing Clinical Trials Overview
6.54 Karp Lab Company Overview
6.54.1 Karp Lab Pipeline Products & Ongoing Clinical Trials Overview
6.55 Kiora Pharmaceuticals Inc Company Overview
6.55.1 Kiora Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
6.56 Kytogenics Pharmaceuticals Inc Company Overview
6.56.1 Kytogenics Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
6.57 Laboratoire HRA Pharma SAS Company Overview
6.57.1 Laboratoire HRA Pharma SAS Pipeline Products & Ongoing Clinical Trials Overview
6.58 Lachesis Biosciences Ltd Company Overview
6.58.1 Lachesis Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.59 Leyden Laboratories BV Company Overview
6.59.1 Leyden Laboratories BV Pipeline Products & Ongoing Clinical Trials Overview
6.60 Lobe Sciences Ltd Company Overview
6.60.1 Lobe Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.61 Lyra Therapeutics Inc Company Overview
6.61.1 Lyra Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.62 Magee-Womens Research Institute Company Overview
6.62.1 Magee-Womens Research Institute Pipeline Products & Ongoing Clinical Trials Overview
6.63 MassBiologics Company Overview
6.63.1 MassBiologics Pipeline Products & Ongoing Clinical Trials Overview
6.64 McNeil AB Company Overview
6.64.1 McNeil AB Pipeline Products & Ongoing Clinical Trials Overview
6.65 Medlab Clinical Ltd Company Overview
6.65.1 Medlab Clinical Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.66 Merck & Co Inc Company Overview
6.66.1 Merck & Co Inc Pipeline Products & Ongoing Clinical Trials Overview
6.67 Merck Serono SA Company Overview
6.67.1 Merck Serono SA Pipeline Products & Ongoing Clinical Trials Overview
6.68 Mucommune LLC Company Overview
6.68.1 Mucommune LLC Pipeline Products & Ongoing Clinical Trials Overview
6.69 Mycrodose Therapeutics Inc Company Overview
6.69.1 Mycrodose Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.70 Mystic Pharmaceuticals Inc Company Overview
6.70.1 Mystic Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
6.71 Nanosys Inc Company Overview
6.71.1 Nanosys Inc Pipeline Products & Ongoing Clinical Trials Overview
6.72 Nasus Medical Inc Company Overview
6.72.1 Nasus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.73 Nasus Pharma Ltd Company Overview
6.73.1 Nasus Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.74 Nemera La Verpilliere Company Overview
6.74.1 Nemera La Verpilliere Pipeline Products & Ongoing Clinical Trials Overview
6.75 NorInvent AB Company Overview
6.75.1 NorInvent AB Pipeline Products & Ongoing Clinical Trials Overview
6.76 Novlead Biotechnology Co Ltd Company Overview
6.76.1 Novlead Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.77 Olfax LLC Company Overview
6.77.1 Olfax LLC Pipeline Products & Ongoing Clinical Trials Overview
6.78 Opiant Pharmaceuticals Inc Company Overview
6.78.1 Opiant Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
6.79 OptiNose AS Company Overview
6.79.1 OptiNose AS Pipeline Products & Ongoing Clinical Trials Overview
6.80 OptiNose Inc Company Overview
6.80.1 OptiNose Inc Pipeline Products & Ongoing Clinical Trials Overview
6.81 Organon Pharma (UK) Ltd Company Overview
6.81.1 Organon Pharma (UK) Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.82 Orion Biotechnology Canada Ltd Company Overview
6.82.1 Orion Biotechnology Canada Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.83 Orphanse Healthcare SAS Company Overview
6.83.1 Orphanse Healthcare SAS Pipeline Products & Ongoing Clinical Trials Overview
6.84 Oyster Point Pharma Inc Company Overview
6.84.1 Oyster Point Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
6.85 P&B Group Company Overview
6.85.1 P&B Group Pipeline Products & Ongoing Clinical Trials Overview
6.86 Palette Life Sciences AB Company Overview
6.86.1 Palette Life Sciences AB Pipeline Products & Ongoing Clinical Trials Overview
6.87 Parnell Pharmaceuticals Inc Company Overview
6.87.1 Parnell Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
6.88 Phoenix Life Sciences International Ltd Company Overview
6.88.1 Phoenix Life Sciences International Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.89 pHOXBIO Ltd Company Overview
6.89.1 pHOXBIO Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.90 Pocket Naloxone Corp Company Overview
6.90.1 Pocket Naloxone Corp Pipeline Products & Ongoing Clinical Trials Overview
6.91 Polyrizon Ltd Company Overview
6.91.1 Polyrizon Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.92 RDD Pharma Ltd (Inactive) Company Overview
6.92.1 RDD Pharma Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.93 Receptor Life Sciences Inc Company Overview
6.93.1 Receptor Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
6.94 Renown Pharmaceuticals Pvt Ltd Company Overview
6.94.1 Renown Pharmaceuticals Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.95 Rhinomed Ltd Company Overview
6.95.1 Rhinomed Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.96 Sanotize Research and Development Corp Company Overview
6.96.1 Sanotize Research and Development Corp Pipeline Products & Ongoing Clinical Trials Overview
6.97 Scientus Pharma Inc Company Overview
6.97.1 Scientus Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
6.98 Seelos Therapeutics, Inc. Company Overview
6.98.1 Seelos Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.99 Shin Nippon Biomedical Laboratories Ltd Company Overview
6.99.1 Shin Nippon Biomedical Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.100 SipNose Ltd Company Overview
6.100.1 SipNose Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.101 South Valley University Company Overview
6.101.1 South Valley University Pipeline Products & Ongoing Clinical Trials Overview
6.102 Starpharma Holdings Ltd Company Overview
6.102.1 Starpharma Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.103 The Population Council Inc Company Overview
6.103.1 The Population Council Inc Pipeline Products & Ongoing Clinical Trials Overview
6.104 Therakind Ltd Company Overview
6.104.1 Therakind Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.105 Union Therapeutics AS Company Overview
6.105.1 Union Therapeutics AS Pipeline Products & Ongoing Clinical Trials Overview
6.106 University of California Davis Company Overview
6.106.1 University of California Davis Pipeline Products & Ongoing Clinical Trials Overview
6.107 University of Erlangen-Nurnberg Company Overview
6.107.1 University of Erlangen-Nurnberg Pipeline Products & Ongoing Clinical Trials Overview
6.108 University of Kentucky Company Overview
6.108.1 University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview
6.109 University of Louisville Company Overview
6.109.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
6.110 University of Melbourne Company Overview
6.110.1 University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview
6.111 University of North Carolina at Chapel Hill Company Overview
6.111.1 University of North Carolina at Chapel Hill Pipeline Products & Ongoing Clinical Trials Overview
6.112 University of Pittsburgh Company Overview
6.112.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
6.113 University of South Florida Company Overview
6.113.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
6.114 University of Texas at Austin Company Overview
6.114.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
6.115 University of the Witwatersrand Company Overview
6.115.1 University of the Witwatersrand Pipeline Products & Ongoing Clinical Trials Overview
6.116 University of Waterloo Company Overview
6.116.1 University of Waterloo Pipeline Products & Ongoing Clinical Trials Overview
6.117 Virpax Pharmaceuticals Inc Company Overview
6.117.1 Virpax Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
6.118 VistaGen Therapeutics Inc Company Overview
6.118.1 VistaGen Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.119 Washington University in St Louis Company Overview
6.119.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview
6.120 Wellfully Ltd Company Overview
6.120.1 Wellfully Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.121 Xlear Inc Company Overview
6.121.1 Xlear Inc Pipeline Products & Ongoing Clinical Trials Overview
6.122 Zydus Healthcare Ltd Company Overview
6.122.1 Zydus Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview
7 Transmucosal Drug Delivery- Recent Developments
7.1 May 12, 2023: Impel Pharmaceuticals announces first quarter 2023 financial results and provides business update
7.2 May 10, 2023: AcelRx Pharmaceuticals reports first quarter 2023 financial results and provides corporate update
7.3 May 04, 2023: Daré Bioscience to host Q1 2023 financial results and company update conference call and webcast on May 11, 2023
7.4 Apr 28, 2023: Candace Matthews elected independent chairperson of Aptar’s board of directors
7.5 Apr 12, 2023: Impel Pharmaceuticals Announces Appointment of Darren Cline to the Board of Directors
7.6 Mar 31, 2023: Daré Bioscience Reports First Quarter 2023 Financial Results and Provides a Company Update
7.7 Mar 30, 2023: Daré Bioscience Reports Full Year 2022 Financial Results and Provides a Company Update
7.8 Mar 24, 2023: Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
7.9 Mar 17, 2023: Impel Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 24, 2023
7.10 Feb 16, 2023: Marinomed Biotech announces preliminary revenue for 2022 with double-digit growth for Carragelose
7.11 Dec 02, 2022: Neurelis to present nine posters at the 76th American Epilepsy Society Annual Meeting
7.12 Nov 30, 2022: Optinose announces corporate updates and Presentation at the 34th Annual Piper Sandler Healthcare Conference
7.13 Nov 30, 2022: Recipharm invests in its single dose nasal platform capabilities
7.14 Nov 22, 2022: Distinguished Cancer and Stem Cell Biologist Ulrich Steidl M.D. Ph.D. Appointed Chair of Cell Biology at Albert Einstein College of Medicine
7.15 Nov 14, 2022: AcelRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7.16 Nov 10, 2022: Dare Bioscience Reports Third Quarter 2022 Financial Results and Provides a Company Update
7.17 Nov 10, 2022: Aptar Mumbai announces new facility construction
7.18 Nov 04, 2022: Avanir files WARN notice for 100+ layoffs from California as merger with parent Otsuka looms
7.19 Nov 01, 2022: Cognitive Research Corp. Appoints Jeff Williams as Executive Chairman Following Growth Equity Transaction
7.20 Nov 01, 2022: New study confirms ColdZyme stops viruses causing Covid-19 from adhering to human respiratory cells
7.21 Oct 31, 2022: Aptar Pharma completes first phase of global injectables expansion program
7.22 Oct 18, 2022: Aptar Digital Health announces strategic partnership with the Chiesi Group
7.23 Oct 11, 2022: Aptar Digital Health launches new disease management platform
7.24 Aug 15, 2022: Impel Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update
7.25 Aug 12, 2022: AcelRx Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7.26 Jul 28, 2022: Cosmo reports strong half-year 2022 financial results delivering record revenues and reaffirms 2022 full-year guidance
7.27 Jul 13, 2022: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2022 Financial Results
7.28 Jul 12, 2022: Aspire & USF Pass $10M in ticket & donation revenue
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Transmucosal Drug Delivery - Pipeline Products by Stage of Development
Table 2: Transmucosal Drug Delivery - Pipeline Products by Segment
Table 3: Transmucosal Drug Delivery - Pipeline Products by Territory
Table 4: Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
Table 5: Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
Table 6: Transmucosal Drug Delivery - Ongoing Clinical Trials
Table 7: Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development
Table 8: Transmucosal Drug Delivery – Companies Pipeline Products by Stage of Development
Table 9: AcelRx Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Zalviso - Product Status
Table 11: Zalviso - Product Description
Table 12: AcelRx Pharmaceuticals Inc - Ongoing Clinical Trials Overview
Table 13: Zalviso - Treatment of Acute Post-operative Pain in Patients Undergoing Laparoscopic Colon Resections
Table 14: AFYX Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Rivelin - CLO Patch - Product Status
Table 16: Rivelin - CLO Patch - Product Description
Table 17: Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Drug-Impregnated Intravaginal Ring - Product Status
Table 19: Drug-Impregnated Intravaginal Ring - Product Description
Table 20: Allergan Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Vaginal Ring - Product Status(Allergan Ltd)
Table 22: Vaginal Ring - Product Description(Allergan Ltd)
Table 23: Altamira Medica AG Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Bentrio - Viral Infections - Product Status
Table 25: Bentrio - Viral Infections - Product Description
Table 26: Altamira Medica AG - Ongoing Clinical Trials Overview
Table 27: Bentrio - Viral Infections - A Randomized, Placebo-controlled Clinical Study to Evaluate the Ability of Bentrio Nasal Spray in COVID-19 Patients: COVAMID
Table 28: Bentrio - Viral Infections - Study Evaluating the Efficacy of Bentrio Nasal Spray for Protection Against Airborne Viruses and Allergens in India
Table 29: Anelleo Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: AnelleO PRO - Product Status
Table 31: AnelleO PRO - Product Description
Table 32: Aquestive Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Anaphylm - Product Status
Table 34: Anaphylm - Product Description
Table 35: Arovella Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 36: ArTiMist - Product Status
Table 37: ArTiMist - Product Description
Table 38: ARS Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Neffy - Product Status
Table 40: Neffy - Product Description
Table 41: Atossa Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: AT-301 Nasal Spray - Product Status
Table 43: AT-301 Nasal Spray - Product Description
Table 44: Auris Medical AG Pipeline Products & Ongoing Clinical Trials Overview
Table 45: AM-125 Betahistine Nasal Spray - Product Status
Table 46: AM-125 Betahistine Nasal Spray - Product Description
Table 47: AM-201 Betahistine Nasal Spray - Product Status
Table 48: AM-201 Betahistine Nasal Spray - Product Description
Table 49: Auritec Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: BUP Pod-IVR - Product Status
Table 51: BUP Pod-IVR - Product Description
Table 52: NuvaRing - Product Status
Table 53: NuvaRing - Product Description
Table 54: pod-IVR - Product Status
Table 55: pod-IVR - Product Description
Table 56: Versa Intravaginal Ring - Acromegaly - Product Status
Table 57: Versa Intravaginal Ring - Acromegaly - Product Description
Table 58: Versa Intravaginal Ring - Alzheimer's Disease - Product Status
Table 59: Versa Intravaginal Ring - Alzheimer's Disease - Product Description
Table 60: Versa Intravaginal Ring - Breast Cancer - Product Status
Table 61: Versa Intravaginal Ring - Breast Cancer - Product Description
Table 62: Versa Intravaginal Ring - Endometriosis - Product Status
Table 63: Versa Intravaginal Ring - Endometriosis - Product Description
Table 64: Versa Intravaginal Ring - Herpes - Product Status
Table 65: Versa Intravaginal Ring - Herpes - Product Description
Table 66: Versa Intravaginal Ring - HIV Prophylaxis - Product Status
Table 67: Versa Intravaginal Ring - HIV Prophylaxis - Product Description
Table 68: Versa Intravaginal Ring - Pain And Addiction - Product Status
Table 69: Versa Intravaginal Ring - Pain And Addiction - Product Description
Table 70: Versa Intravaginal Ring - Parkinson's Disease - Product Status
Table 71: Versa Intravaginal Ring - Parkinson's Disease - Product Description
Table 72: Versa Intravaginal Ring - Type II Diabetes - Product Status
Table 73: Versa Intravaginal Ring - Type II Diabetes - Product Description
Table 74: Versa Intravaginal Ring - Uterine Fibroids - Product Status
Table 75: Versa Intravaginal Ring - Uterine Fibroids - Product Description
Table 76: BeFree! Pipeline Products & Ongoing Clinical Trials Overview
Table 77: Vaginal Drug Delivery System - Product Status
Table 78: Vaginal Drug Delivery System - Product Description
Table 79: Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 80: NAS010 - Nasal Drug Delivery Device - Product Status
Table 81: NAS010 - Nasal Drug Delivery Device - Product Description
Table 82: NAS020 - Unidose Nasal Drug Delivery Device - Product Status
Table 83: NAS020 - Unidose Nasal Drug Delivery Device - Product Description
Table 84: NAS030 Nasal Device - Product Status
Table 85: NAS030 Nasal Device - Product Description
Table 86: Biorings LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 87: Vaginal Ring - Product Status(Biorings LLC)
Table 88: Vaginal Ring - Product Description(Biorings LLC)
Table 89: BioXcel Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 90: BXCL501 Sublingual Film - Product Status
Table 91: BXCL501 Sublingual Film - Product Description
Table 92: BioXcel Therapeutics Inc - Ongoing Clinical Trials Overview
Table 93: BXCL501 Sublingual Film - A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of PRN Dosing of BXCL501 Over a 12 Week Treatment Period in Subjects with Agitation Associated with Dementia
Table 94: BXCL501 Sublingual Film - A Study to Evaluate the BXCL501 for At-home Use in Patients with Bipolar Disorder or Schizophrenia
Table 95: Birmingham Biotech Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 96: BHM Anti-Viral Nasal Spray - Product Status
Table 97: BHM Anti-Viral Nasal Spray - Product Description
Table 98: Bryn Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 99: BRYN-NDS1C - Product Status
Table 100: BRYN-NDS1C - Product Description
Table 101: Callitas Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 102: CannaMint Strip - Product Status
Table 103: CannaMint Strip - Product Description
Table 104: Chulalongkorn University Pipeline Products & Ongoing Clinical Trials Overview
Table 105: AntiCov Nasal Spray - Product Status
Table 106: AntiCov Nasal Spray - Product Description
Table 107: Combinent BioMedical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 108: Multi-Segmented Vaginal Ring - Product Status
Table 109: Multi-Segmented Vaginal Ring - Product Description
Table 110: Conrad Pipeline Products & Ongoing Clinical Trials Overview
Table 111: Topical Dual-Compartment Insert - Product Status
Table 112: Topical Dual-Compartment Insert - Product Description
Table 113: Triple Protection Vaginal Ring - Product Status
Table 114: Triple Protection Vaginal Ring - Product Description
Table 115: Vaginal Ring - HIV Protection - Product Status
Table 116: Vaginal Ring - HIV Protection - Product Description
Table 117: Covidrops LLP Pipeline Products & Ongoing Clinical Trials Overview
Table 118: Nasal Spray - COVID-19 - Product Status
Table 119: Nasal Spray - COVID-19 - Product Description
Table 120: Dare Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 121: DARE-FRT1 Intravaginal Ring - Product Status
Table 122: DARE-FRT1 Intravaginal Ring - Product Description
Table 123: DARE-HRT1 Intravaginal Ring - Product Status
Table 124: DARE-HRT1 Intravaginal Ring - Product Description
Table 125: DARE-OAB1 - Product Status
Table 126: DARE-OAB1 - Product Description
Table 127: DARE-VVA1 Intravaginal Ring - Product Status
Table 128: DARE-VVA1 Intravaginal Ring - Product Description
Table 129: Dare Bioscience Inc - Ongoing Clinical Trials Overview
Table 130: DARE-HRT1 Intravaginal Ring - A Phase 1/2, Open-label, Parallel Group Study to Evaluate the Safety and Pharmacokinetics of DARE-HRT1 (80ug Estradiol/4 Mg Progesterone and 160ug Estradiol/8 Mg Progesterone Intravaginal Rings) Over 12 Weeks in Healthy Postmenopausal Women
Table 131: Eledon Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 132: OP0201 - Product Status
Table 133: OP0201 - Product Description
Table 134: Emergent BioSolutions Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 135: SIAN - Product Status
Table 136: SIAN - Product Description
Table 137: Emergent BioSolutions Inc - Ongoing Clinical Trials Overview
Table 138: SIAN - Phase 1, Open Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Stabilized Isoam

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings